Table 3.
NF-κB staining pattern changes and clinical outcome
| Characteristic | Change to positive1 | Change to negative2 | No change3 | p-value |
|---|---|---|---|---|
| Survival | ||||
| Alive | 4 | 0 | 4 | .09 |
| Dead | 1 | 3 | 4 | |
| Disease-specific Survival | ||||
| Alive | 4 | 0 | 5 | .08 |
| Dead | 1 | 3 | 3 | |
| Distant Metastases | ||||
| Yes | 2 | 3 | 3 | .16 |
| No | 3 | 0 | 5 | |
| Local-regional failure4 | ||||
| Yes | 0 | 3 | 3 | .02 |
| No | 5 | 0 | 5 |
1
negative in pre-radiation specimen and subsequently positive in specimen taken 48 hours after treatment initiation
2
positive in pre-radiation specimen and subsequently negative in specimen taken 48 hours after treatment initiation
3
no change in positivity or negativity between the patient specimens
4
local-regional includes central, pelvic, and para-aortic relapses